Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2026-01-11 @ 3:09 AM
Study NCT ID:
NCT01311661
Status:
COMPLETED
Last Update Posted:
2014-05-01
First Post:
2011-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma
Sponsor:
Boehringer Ingelheim
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Asthma | View |
Keywords: